Preclinical Assessment of the Cardiotoxic Potential of Anthracycline Antibiotics: N-L-Leucyl-Doxorubicin
The primary task of industrial toxicologists is to provide a comprehensive assessment of the adverse effects of selected chemical substances in several animal species and over a broad range of doses. Increasingly, their collaboration is also required when a compound has caused serious toxicity in humans or animals, and when it is decided to modify the chemical structure, in an effort to reduce or to eliminate the undesirable properties. In such programs it is often necessary to assess a considerable number of newly synthesized substances. Moreover, the results of the toxicity tests must be available within a short period of time, and they must be quantitative, so as to provide a rational basis for the synthesis of new derivatives. It is evident that the standard toxicological procedures cannot be used for these purposes, and that a toxicological screening approach has to be developed which differs fundamentally from that on which the conventional safety assessment programs are based (Zbinden et al 1984a). The main differences between conventional safety testing programs and toxicological screening are summarized in Table 1.
KeywordsCardiotoxic Effect Arch Toxicol Anthracycline Antibiotic Equimolar Dose Toxicological Screening
Unable to display preview. Download preview PDF.
- Beijersbergen van Henegouven GMJ (1988) In vitro and in vivo research on phototoxic xenobiotics: structure-activity relationships. Arch Toxicol Suppl 12:3–9Google Scholar
- Deprez-DeCampeneere D, Baurain R, Masquelier M, Trouet A (1980) Toxic and chemotherapeutic effects of L-leucyl-daunorubicin and L-leucyl-doxorubicin after intravenous administration in mice. Current Chemotherapy and Infectious Diseases. Proc. 11th ICC and 19th ICAAC. American Society of Microbiology, pp. 1692–1694Google Scholar
- Magis AJ, Atassi G, Baurain R, DeCampeneere D, Trouet A, Zbinden G (1989) Preclinical development of N-L-leucyl-doxorubicin. Proc. 3rd ARTAC (Association pour la Recherche Thérapeutique Anticancereuse) Workshop. Paris October 19–20Google Scholar
- Zbinden G (1981) Assessment of cardiotoxic effects in subacute and chronic rat toxicity studies. In: Cardiac Toxicology, Ed. T. Balazs, Vol. III, CRP Press Inc. Boca Raton, Fla, pp.7–32Google Scholar
- Zbinden G, Bachmann E, Holderegger Ch (1978) Model system for cardiotoxic effects of anthracyclines. Antibiotics and Chemother 23:255–270Google Scholar